MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

Search

Amedisys Inc

Suletud

SektorTervishoid

94.2 0.71

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

93.2

Max

94.39

Põhinäitajad

By Trading Economics

Sissetulek

-42M

-25M

Müük

10M

598M

P/E

Sektori keskmine

70.099

57.333

Aktsiakasum

0.96

Kasumimarginaal

-4.189

Töötajad

19,000

EBITDA

-23M

3.2M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+7.69% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

29. apr 2025

Turustatistika

By TradingEconomics

Turukapital

-17M

3B

Eelmine avamishind

93.49

Eelmine sulgemishind

94.2

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

Amedisys Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

8. jaan 2025, 23:27 UTC

Omandamised, ülevõtmised, äriostud

UnitedHealth and Amedisys End Sales of Medical Centers to VitalCaring -- Update

8. jaan 2025, 22:47 UTC

Omandamised, ülevõtmised, äriostud

UnitedHealth and Amedisys End Sales of Medical Centers to VitalCaring

8. jaan 2025, 21:57 UTC

Omandamised, ülevõtmised, äriostud

UnitedHealth Group Terminates Deal for Sale of Certain Amedisys and UnitedHealth Assets to VitalCaring Group

27. dets 2024, 17:58 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

Amedisys Stock Gains as Merger Extension Raises Hope for UnitedHealth Deal -- Barrons.com

12. nov 2024, 20:18 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

Justice Department Sues to Block UnitedHealth's $3.3 Billion Bid for Amedisys -- Update

12. nov 2024, 19:34 UTC

Omandamised, ülevõtmised, äriostud

DOJ Lawsuit Threatens to Derail UnitedHealth's Effort to Buy Another Home Health Provider -- Barrons.com

12. nov 2024, 17:42 UTC

Peamised uudised
Omandamised, ülevõtmised, äriostud

Justice Department Sues to Block UnitedHealth's $3.3 Billion Bid for Amedisys -- WSJ

Võrdlus sarnastega

Hinnamuutus

Amedisys Inc Prognoos

Hinnasiht

By TipRanks

7.69% tõus

12 kuu keskmine prognoos

Keskmine 100.83 USD  7.69%

Kõrge 101 USD

Madal 100 USD

Põhineb 8 Wall Streeti analüütiku instrumendi Amedisys Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

8 ratings

1

Osta

7

Hoia

0

Müü

Tehniline skoor

By Trading Central

91.5 / N/AToetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Weak Bullish Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Amedisys Inc

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.